Stocks and Investing Stocks and Investing
Fri, July 21, 2023
Thu, July 20, 2023

Matthew Harrison Maintained (TSVT) at Buy with Decreased Target to $25 on, Jul 20th, 2023


Published on 2024-10-28 04:59:15 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $28 to $25 on, Jul 20th, 2023.

Matthew has made no other calls on TSVT in the last 4 months.



There is 1 other peer that has a rating on TSVT. Out of the 1 peers that are also analyzing TSVT, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $26 on, Thursday, May 18th, 2023

Contributing Sources